[1]
B. . Zhao, M. . Luo, A. . Wang, and W. . Zhang, “MiR-182 antagonist alleviates glucocorticoid-induced secondary bone degeneration and osteoclast differentiation”, Cell Mol Biol (Noisy-le-grand), vol. 67, no. 5, pp. 123–130, Feb. 2022.